Haemonetics Inc., a Blood management Company, has announced its annual results for FY-2014.
The results shows, Revenues down by 3% to $910.4 Million, Adjusted EPS went down by 15% to $1.85.
View the full earnings release here.
Haemonetics Inc., a Blood management Company, has announced its annual results for FY-2014.
The results shows, Revenues down by 3% to $910.4 Million, Adjusted EPS went down by 15% to $1.85.
View the full earnings release here.